GALLAGHER NEIL (President, Head of R&D) received a stock award from SYNDAX PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/7/2025ACC: 0000950170-25-016391
Officer· President, Head of R&D
Since Apr 2023
+152.40K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
152.40K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+18.50K
Price / share
—
Trade value
—
% of position
38.7%
2/5/2025
47.81K→66.31K
Common Stock
Direct
Shares
+23.40K
Price / share
—
Trade value
—
% of position
35.3%
2/5/2025
66.31K→89.71K
Total
Net shares
+41.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/5/2025 | A · Award | +18.50K | — | — | 38.7% | 47.81K | 66.31K |
| Common Stock Direct | 2/5/2025 | A · Award | +23.40K | — | — | 35.3% | 66.31K | 89.71K |
| Total | +41.90K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
110.50K shares
Shares
+110.50K
Strike price
14.65
Held after
110.50K
Exercisable
—
2/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock110.50K shares | 2/5/2025 | A · Award | +110.50K | 14.65 | — | 110.50K |